Skip to main content

Table 2 Characteristics of the completed economic evaluations

From: Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations

Study ID, main referencea

Type and design of analysis

Perspective

Location (city/ cities; country)

Enrolment periodb

Inclusion criteria (disease(s); type(s) of surgery; criteria for increased perioperative risk)

Population demographics

Number of patients randomised (total (IG vs. CG))

AlShewaier 2016 [37]

CUA; trial-based (RCT)

Unclear

Riyadh; Saudi Arabia

07/2014–01/2015

Isolated ACL injury; ACL reconstruction

Female: 0%, male: 100%

Median age: 27 years

84 (39 vs. 45)

Barberan-Garcia 2019 [38]

CCA; trial-based (RCT)

Mix of payer/provider perspective

Barcelona; Spain

02/2013–06/2016

Not specified; major digestive surgery; age > 70 years and/or ASA score ≥ III

Female: 25%, male: 75%

Mean age: 71 years

125 (62 vs. 63)

Beaupre 2004 [39]

CMA; trial-based (RCT)

Payer perspective

Edmonton; Canada

Not reported

Non-inflammatory arthritis; primary TKA

Female: 55%, male: 45%

Mean age: 67 years

131 (65 vs. 66)

Chen 2022 [40]

CBA; model-based (projection)

Provider perspective

Toronto; Canada

Not applicable (model)

Not specified; major elective intra-cavity surgery; higher-than-average risk, limited physiologic reserve, frailty, deconditioned patient, other indication for prehabilitation with explanation

Not reported

480 (240 vs. 240)

Dholakia 2021 [41]

CEA; model-based (decision tree)

Payer perspective

Not reported; USA

Not applicable (model)

Epithelial ovarian cancer; non-emergent primary debulking surgery; frailty

Female: 100%, male: 0%

Age not reported

8830 (4415 vs. 4415)

Englesbe 2017 [29]

CMA; trial-based (NRSI)

Mix of payer/provider perspective

Ann Arbor; USA

IG: 06/2014–12/2015c

CG: 07/2006–06/2011

Not specified; major inpatient abdominal and thoracic operative care

Female: 50%, male: 50%

Mean age: 60 years

364 (182 vs. 182)

Fernandes 2017 [42]

CUA; trial-based (RCT)

Mix of payer/ provider/patient perspective

Svendborg; Denmark

01/2010–03/2011

Symptomatic osteoarthritis; TKA, THA

Female: 56%, male: 44%

Mean age: 67 years

165 (84 vs. 81)

Gao 2015 [43]

CCA; trial-based (NRSI)

Unclear

Chengdu; China

11/2008–06/2011

Lung cancer; lobectomy; > 800 pack-years, quitted smoking < 2 weeks ago, bronchial hyperresponsiveness, impaired lung function

Female: 59%, male: 41%

Mean age: 66 years

142 (71 vs. 71)

Gränicher 2020 [44]

CCA; trial-based (RCT)

Payer perspective

Zürich; Switzerland

07/2016–03/2017

Not specified; TKA

Female: 40%, male: 60%

Mean age: 67 years

20 (10 vs. 10)

Howard 2019 [30]

CCA; trial-based (NRSI)

Mix of payer/ provider perspective

Ann Arbor; USA

01/2012–12/2017c

Not specified; major abdominal surgery

Female: 49%, male: 51%

Mean age: 59 years

116 (76 vs. 40)

Huang 2012 [45]

CCA; trial-based (RCT)

Provider perspective

Changhua; Taiwan

01/2008–12/2010

Advanced osteoarthritis; primary TKA

Female: 72%, male: 28%

Mean age: 70 years

243 (126 vs. 117)

Koh 2021 [46]

CCA; trial-based (NRSI)

Patient perspective

Singapore; Singapore

IG: 02/2017–03/2020

CG: 04/2016–09/2018

Colorectal cancer; major colectomy; age ≥ 70 years

Female: 44%, male: 56%

Median age: 78 years

81 (58 vs. 23)

Lai 2017 [32]

CCA; trial-based (RCT)

Unclear; assumed provider perspective

Chengdu; China

01/2015–12/2015d

Non-small cell lung cancer; lung cancer surgery; > 20 pack-years, age > 75 years, BMI > 30, impaired predicted lung function or COPD

Female: 42%, male: 58%

Mean age: 64 years

101 (51 vs. 50)

Lai 2019 [33]

CCA; trial-based (RCT)

Unclear; assumed provider perspective

Chengdu; China

01/2018-not reported

Non-small cell lung cancer; lobectomy

Female: 51%, male: 49%

Mean age: 64 years

68 (34 vs. 34)

McGregor 2004 [47]

CEA; trial-based (RCT)

Mix of payer/provider perspective

London; UK

Not reported

Not specified; THA

Female: 71%, male: 29%

Mean age: 72 years

39 (19 vs. 20)

Mouch 2019 [31]

CMA; trial-based (NRSI)

Mix of payer/provider perspective

Multiple cities in Michigan; USA

01/2014–12/2017c

Not specified; various types of surgery; high risk for complications (according to surgeon)

Female: 53%, male: 47%

Median age: 70 years

1569 (523 vs. 1046)

Nguyen 2022 [48]

CUA; trial-based (RCT)

Mix of payer/provider perspective

Paris, Clermont-Ferrand; France

10/2012- not reported

Knee osteoarthritis; TKA

Female: 68%, male: 32%

Mean age: 69 years

262 (131 vs. 131)

Pham 2016 [49]

CMA; trial-based (RCT)

Unclear; assumed provider perspective

Sudbury; Canada

Not reported

Osteoarthritis; TKA, THA; BMI ≥ 30

Female: 69%, male: 31%

Mean age: 64 years

50 (29 vs. 21)

Ploussard 2020 [50]

CCA; trial-based (NRSI)

Mix of payer/provider perspective

Quint-Fonsegrives; France

IG: 01/2018–12/2019

CG: 01/2016–12/2017

Not specified; robot-assisted radical prostatectomy

Female: 0%, male: 100%

Mean age: 66 years

350 (194 vs. 156)

Risco 2022 [51]

CCA; trial-based (NRSI)

Provider perspective

Barcelona, Spain

06/2017–12/2019

Not specified; major digestive, cardiac, thoracic, gynaecologic or urologic surgeries; age > 70 years and/or ASA score ≥ III and/or severe deconditioning

Female: 69%, male: 31%

Median age 71 years

656 (328 vs. 328)

Tew 2017 [52]

CEA; trial-based (RCT)

Mix of payer/provider perspective

Middlesbrough, Sheffield, York; UK

09/2013–07/2015

Abdominal aortic aneurysms; abdominal aortic aneurysm repair

Female: 6%, male: 94%

Mean age: 75 years

53 (27 vs. 26)

Tveter 2020 [53]

CUA; trial-based (RCT)

Unclear; assumed mix of provider, payer and patient perspective

Trondheim, Bergen, Haugesund; Norway

04/2013–06/2015

Carpometacarpal joint osteoarthritis; thumb carpometacarpal joint surgery

Female: 79%, male: 21%

Mean age: 63 years

180 (90 vs. 90)

Van Wijk 2020 [54]

CBA; model-based (decision tree)

Not reported

Netherlands (nationwide)

Not applicable (model)

Not specified; pancreatic surgery; low physical fitness, impaired nutritional status, the presence of iron deficiency anaemia, frailty, and/or intoxications

Not reported

Not reported

Wang 2020 [55]

CCA; trial-based (NRSI)

Unclear; assumed provider perspective

Singapore; Singapore

02/2016–10/2017

Hepatocellular carcinoma, colorectal liver metastases; liver resection

Female: 26%, male: 74%

Median age: 67 years

104 (70 vs. 34)

Zhou 2017 [34]

CCA; trial-based (NRSI)

Unclear; assumed patient perspective

Chengdu; China

03/2014–06/2015d

Primary non-small cell lung cancer; lobectomy; ≥ 20 pack-years, BMI ≥ 28, impaired lung function, COPD/asthma/airway hyper reactivity

Female: 56%, male: 44%

Mean age: 59 years

939 (197 vs. 742)

  1. ACL anterior cruciate ligament, ASA American Society of Anesthesiologists, BMI body mass index, CBA cost–benefit analysis, CCA cost–consequence analysis, CEA cost-effectiveness analysis, CG control group, CMA cost-minimisation analysis, COPD chronic obstructive pulmonary disease, CUA cost–utility analysis, IG intervention group, NRSI non-randomised study of interventions, RCT randomised controlled trial, THA total hip arthroplasty, TJA total joint arthroplasty, TKA total knee arthroplasty, UK United Kingdom, USA United States of America
  2. a Further references relating to the included economic evaluations are cited in Additional file 1: Appendix 7
  3. b Extracted from article or registration record (in that order)
  4. c Overlapping population (Michigan, United States)
  5. d Overlapping population (Chengdu, China)